This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A singular database of current rules, guidelines and best practices in radiology would be a welcome advance to ensure ease of access, consistency, and proactive prevention of frivolous malpractice cases.
Last week, Radiology Partners released an announcement that it was “commencing a comprehensive set of financing transactions to strengthen its financial position.” Setting the Stage Going into 2024, RP was already cashflow negative (i.e. losing money) to say nothing of the massive debt payments due this year and next. For a reminder of what was coming, recall this slide: But it’s more than that: In addition to having no ability to pay these loans back, RP told lenders they̵
MRI radiomics features can differentiate breast cancers based on human epidermal growth factor receptors (HERs), according to research published January 24 in the American Journal of Roentgenology. Researchers led by Yuqin Peng from Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University in Guangzhou, Guangdong found that their nomogram based on MRI radiomics can distinguish HER2-zero from HER2-low or HER2-positives cancers, as well as HER2-low from HER2-positive cancers.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Increasing use of cloud and AI are among the trends observed by Amy Thompson, research manager for healthcare IT at the healthcare market analysis firm Signify Research, at RSNA 2023.
As you might recall, UnitedHealthcare sued Radiology Partners in April 2023 for an alleged pass-through billing scheme during an ongoing arbitration process about underpayment initiated by RP’s subsidiary group Singleton Associates in April 202 2. RP called shenanigans. The judge made them fold that complaint into the ongoing arbitration process, in which there are currently three phases: Phase I: Determine which contract is active and should be used to determine charges: the original very
Shear wave elastography (SWE) could be used as an indicator of the risk of breast implant rupture, a study published January 20 in the Journal of Biomechanics. Researchers led by Laetitia Ruffenach, MD, from the University of Strasbourg in France reported that elastography can visualize breast implant stiffness as implants degrade over time, measuring rupture risk and helping diagnose replacements for implants.
Arizona Diagnostic Radiology is buying the Phoenix-area outpatient locations from Evernorth Care Group, the medical practice division of Cigna HealthCare of Arizona.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
In a recently issued statement from multiple radiology societies including the RSNA and ACR, researchers offer practical advice for evaluating artificial intelligence (AI) tools, implementing AI into current workflows and monitoring of the technology to help ensure optimal benefit and effectiveness.
Out-of-network billing by radiologists – often referred to as “surprise billing” – dropped significantly beginning in 2007 and imaging claims are now almost completely in network, according to a recent study. In an analysis of billing trends, the rate of out-of-network (OON) imaging claims declined from 12.6% in 2007 to 1.1% in 2021, with the decline occurring broadly across imaging modalities, noted lead author Jay Parikh, MD, of the University of Texas MD Anderson Cancer Center in Houston.
The administration is reportedly mulling a sale of the Federal Helium Reserve System, a move that could cut off the flow of helium to imaging providers.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
In a nearly two-year study of over 300,000 CT exams, researchers noted a 56.8 percent increase in the frequency of automated CT protocols for outpatient CT examinations.
PET/CT imaging can serve as a metabolic guide to increase the accuracy of needle biopsies in patients with suspicious lung nodules, according to a study published January 18 in the European Journal of Radiology. A team that included researchers in the U.K., Greece, and the U.S. studied whether F-18 FDG-PET/CT scans showing metabolic activity of suspicious nodules improved the accuracy of CT-guided biopsies, and the group recommended the approach based on the results.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Researchers found that several measurements of background parenchymal enhancement (BPE) on dynamic contrast-enhanced MRI were linked to a 27 to 66 percent higher risk of breast cancer recurrence.
In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. The finding suggests that FAPI-PET/CT could serve as a sensitive, reliable, and reproducible imaging technique for these patients, in whom detection rates of primary tumors are low, noted Bingxin Gu, MD, of Fudan University in Shanghai, China, a
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Patients with localized high-risk prostate cancer and midline radiotracer activity in the prostate had over double the incidence of urethral hyperintensity on T2W MRI, according to research presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (ASCO-GU).
Breast cancer incidence rates have risen over the past two decades among younger women, a study published January 26 in JAMA Network Open found. Researchers led by Adetunji Toriola, MD, PhD, from Washington University in St. Louis found higher incidence rates among non-Hispanic Black women ages 20 to 29 and 30 to 39. They also found higher incidence rates for estrogen receptor (ER)-positive, stage I, and stage IV tumors.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content